JAGX 424B3: Shelf registration

Jaguar Health

Filed with the SEC on · accession 0001193125-26-452676

JAGX filed a 424B3 (prospectus (offering)) with the SEC on Nov 9, 2026. Jaguar Health filed a prospectus supplement under Rule 424(b)(3) covering the sale of up to $75,000,000 of common stock, preferred stock, warrants, subscription rights, and units from time to time. The stock moved +7.9% by the first close after the filing.

Summary of the filing

Jaguar Health filed a prospectus supplement under Rule 424(b)(3) covering the sale of up to $75,000,000 of common stock, preferred stock, warrants, subscription rights, and units from time to time. The company noted it is no longer subject to the offering limitations of General Instruction I.B.6 of Form S-3.

Key details

Maximum aggregate public offering price of securities registered under the shelf prospectus$75.0M
IssuerJaguar Health, Inc.

How JAGX stock reacted

Close before

$0.40

Nov 6, 2026

First close after

+7.87%

$0.44

5 trading days

—

Since filing

-1.09%

$0.40

✦ Ask GOAX AI about this filing — what it means for JAGX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for JAGX?

Click here

Frequently asked questions

What did JAGX file with the SEC on Nov 9, 2026?

JAGX filed a 424B3 (Shelf registration). Jaguar Health filed a prospectus supplement under Rule 424(b)(3) covering the sale of up to $75,000,000 of common stock, preferred stock, warrants, subscription rights, and units from time to time. The company noted it is no longer subject to the offering limitations of General Instruction I.B.6 of Form S-3.

What does a shelf registration mean for JAGX stock?

New shares dilute existing holders and are often sold at a discount to the market price.

How do I read a 424B3?

The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.

How did JAGX stock react to this filing?

JAGX closed at $0.40 before the filing and $0.44 on Nov 9, 2026 (+7.87%).

Other JAGX SEC filings

Get alerts when JAGX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days